Lv43
480 积分 2024-01-22 加入
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis
19天前
已完结
Nanobody targets TNF and IL-6 for additive efficacy
19天前
已完结
Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD
19天前
已完结
Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis
20天前
已完结
Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist
22天前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
22天前
已完结
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis
22天前
已完结
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?
23天前
已完结
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
1个月前
已完结
Model-informed precision dosing in inflammatory bowel diseases
4个月前
已完结
皖公网安备34019202002308
